Algeria still reports a 13.9% in the mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70, unchanged since 2018.
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Algeria
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Algeria
CVD, cancer, diabetes or CRD
More indicators for Algeria
Out-of-pocket expenditure PPP per capita
intl dollar259
-intl dollar5
(2021)
Newborns protected against tetanus
97%
-1%
(2022)
Female wasting in children
2.4%
-1.4%
(2019)
Birth registration
99.6%
0%
(2019)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
44.9%
-3%
(2019)
Algeria CVD, cancer, diabetes or CRD between 2000 and 2019
| Period | CVD, cancer, diabetes or CRD | Change |
|---|---|---|
| 2019 | 13.9% | 0% |
| 2018 | 13.9% | -0.2% |
| 2017 | 14.1% | -0.1% |
| 2016 | 14.2% | -0.1% |
| 2015 | 14.3% | 0% |
| 2014 | 14.3% | -0.2% |
| 2013 | 14.5% | -0.3% |
| 2012 | 14.8% | -0.2% |
| 2011 | 15% | -0.2% |
| 2010 | 15.2% | -0.3% |
| 2009 | 15.5% | -0.2% |
| 2008 | 15.7% | -0.3% |
| 2007 | 16% | -0.3% |
| 2006 | 16.3% | -0.3% |
| 2005 | 16.6% | -0.2% |
| 2004 | 16.8% | -0.2% |
| 2003 | 17% | -0.1% |
| 2002 | 17.1% | -0.2% |
| 2001 | 17.3% | -0.3% |
| 2000 | 17.6% |